Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer RA, van Geel PP, Pinto YM, Suurmeijer AJ, Crijns HJ, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. Among authors: van gilst wh, van geel pp, van veldhuisen dj. J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017. J Cardiovasc Pharmacol. 2002. PMID: 11904535
The pharmacological management of heart failure: too many treatments?
van Veldhuisen DJ, van Gilst WH. van Veldhuisen DJ, et al. Among authors: van gilst wh. Eur J Heart Fail. 2003 Jan;5(1):5-8. doi: 10.1016/s1388-9842(02)00159-9. Eur J Heart Fail. 2003. PMID: 12559208 Free article. Review. No abstract available.
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
Willenheimer R, Erdmann E, Follath F, Krum H, Ponikowski P, Silke B, Van Veldhuisen DJ, Van De Ven L, Verkenne P, Lechat P; CIBIS-III investigators. Willenheimer R, et al. Among authors: van de ven l, van veldhuisen dj. Eur J Heart Fail. 2004 Jun;6(4):493-500. doi: 10.1016/j.ejheart.2003.12.016. Eur J Heart Fail. 2004. PMID: 15182776 Free article. Clinical Trial.
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
de Boer RA, Pokharel S, Flesch M, van Kampen DA, Suurmeijer AJ, Boomsma F, van Gilst WH, van Veldhuisen DJ, Pinto YM. de Boer RA, et al. Among authors: van gilst wh, van kampen da, van veldhuisen dj. J Mol Med (Berl). 2004 Oct;82(10):678-87. doi: 10.1007/s00109-004-0579-3. Epub 2004 Aug 20. J Mol Med (Berl). 2004. PMID: 15322702
Non-compliance in patients with heart failure; how can we manage it?
van der Wal MH, Jaarsma T, van Veldhuisen DJ. van der Wal MH, et al. Among authors: van veldhuisen dj. Eur J Heart Fail. 2005 Jan;7(1):5-17. doi: 10.1016/j.ejheart.2004.04.007. Eur J Heart Fail. 2005. PMID: 15642526 Free article. Review.
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Flather MD, et al. Among authors: van veldhuisen dj. Eur Heart J. 2005 Feb;26(3):215-25. doi: 10.1093/eurheartj/ehi115. Epub 2005 Jan 9. Eur Heart J. 2005. PMID: 15642700 Clinical Trial.
1,172 results